G&S Capital LLC Astrazeneca PLC Transaction History

G&S Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 21, 2021	SELL	$48.52 - $58.02 $1.25 Million - $1.5 Million	-25,801 Closed	0 $0
Q3 2020 Oct 21, 2020	BUY	$53.07 - $61.1 $1.37 Million - $1.58 Million	25,801 New	25,801 $1.41 Million
Q2 2020 Jul 24, 2020	SELL	$43.1 - $55.31 $8,318 - $10,674	-193 Closed	0 $0
Q1 2019 Apr 22, 2019	BUY	$35.49 - $43.02 $6,849 - $8,302	193 New	193 $8,000

1,340

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $214B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of G&S Capital LLC, based on Form 13F filings with the SEC.

Stay updated on G&S Capital LLC with notifications on news.